SCHEMBL1453554

SCHEMBL1453554

Cc1ccc(S(=O)(=O)O)c(Cc2cc([N+](=O)[O-])ccc2[N+](=O)[O-])c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.43
CYP3A4 P08684 3/20 0.43
GPR35 Q9HC97 2/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.40
MAPK1 P28482 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
CYP19A1 P11511 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NT5E P21589 1/20 0.40
ACHE P22303 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.39
PDE2A O00408 1/20 0.38
PDE5A O76074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1453562 1.00 TSHR (0.43) TSHRCYP3A4GPR35ALDH1A1CYP1A2
SCHEMBL6005448 0.91 CYP1A2 (0.47) TSHRCYP3A4GPR35ALDH1A1CYP1A2
SCHEMBL283800 0.91 CYP1A2 (0.47) TSHRCYP3A4GPR35ALDH1A1CYP1A2
SCHEMBL196533 0.86 ACHE (0.46) TSHRCYP3A4ALDH1A1MAPK1MEN1
SCHEMBL1228376 0.86 ACHE (0.46) TSHRCYP3A4ALDH1A1MAPK1MEN1
SCHEMBL1607271 0.84 ACHE (0.46) TSHRALDH1A1MEN1KMT2ANT5E
SCHEMBL6553330 0.84 ACHE (0.46) TSHRALDH1A1MEN1KMT2ANT5E
SCHEMBL284469 0.81 TSHR (0.41) TSHRCYP3A4ALDH1A1MEN1KMT2A
SCHEMBL1476156 0.81 TSHR (0.41) TSHRCYP3A4ALDH1A1MEN1KMT2A
SCHEMBL14991279 0.80 AMY1A (0.44) TSHRALDH1A1CYP2C9CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0465064-B1 Process for forming patterns FUJITSU LTD (JP) 1998-12-09 EP claimed
EP-0465064-A2 Resist and process for forming patterns using the same FUJITSU LIMITED (JP) 1992-01-08 EP claimed
US-12578638-B2 Photopolymer composition for hologram formation, hologram recording medium and optical elements LG CHEM, LTD. (KR) 2026-03-17 US disclosed
US-20250297091-A1 PHOTOPOLYMER COMPOSITION, PHOTOPOLYMER FILM, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL ELEMENT AND HOLOGRAPHIC RECORDING METHOD LG CHEM, LTD. (KR) 2025-09-25 US disclosed
EP-3733784-B1 PHOTOPOLYMER COMPOSITION LG CHEMICAL LTD (KR) 2025-07-30 EP disclosed
US-12371521-B2 Photosensitive composition, hologram recording medium using the same, hologram optical element, and method of forming hologram diffraction grating Sony Group Corporation (JP) 2025-07-29 US disclosed
US-20250013197-A1 HOLOGRAPHIC RECORDING MEDIUM, COMPOSITION FOR FORMING PHOTOPOLYMER LAYER AND OPTICAL ELEMENT LG CHEM, LTD. (KR) 2025-01-09 US disclosed
US-12094507-B2 Hologram recording composition, hologram recording medium, diffraction optical element, and optical device, optical component, and image display device using diffraction optical element Sony Group Corporation (JP) 2024-09-17 US disclosed
US-12001141-B2 Photopolymer composition LG CHEM LTD. (KR) 2024-06-04 US disclosed
US-11994704-B2 Hologram medium LG CHEM, LTD. (KR) 2024-05-28 US disclosed
US-11851515-B2 Photopolymer composition LG CHEM, LTD. (KR) 2023-12-26 US disclosed
US-20070097471-A1 Fabrication process for cholesteric liquid crystal media having a volume hologram DAI NIPPON PRINTING CO., LTD. 2007-05-03 US disclosed
US-20070097299-A1 Fabrication process for cholesteric liquid crystal media having a volume hologram DAI NIPPON PRINTING CO., LTD. 2007-05-03 US disclosed
US-20070085334-A1 Indicator for indicating authenticity DAI NIPPON PRINTING CO., LTD. (JP) 2007-04-19 US disclosed
US-20060109531-A1 Laser marking hologram and hologram-oriented laser marking method DAI NIPPON PRINTING CO., LTD. 2006-05-25 US disclosed
US-7018744-B2 Volume type hologram recording photosensitive composition, volume type hologram recording medium using the same and method of producing volume type hologram DAI NIPPON PRINTING CO, LTD (JP) 2006-03-28 US disclosed
US-20040137334-A1 Volume hologram recording photosensitive composition, volume hologram recording photosensitive medium and volume hologram DAI NIPPON PRINTING CO., LTD. (JP) 2004-07-15 US disclosed
US-20030087163-A1 Volume type hologram recording photosensitive composition, volume type hologram recording medium using the same and method of producing volume type hologram DAI NIPPON PRINTING CO., LTD. (JP) 2003-05-08 US disclosed
EP-0465064-B1 Process for forming patterns FUJITSU LTD (JP) 1998-12-09 EP disclosed
EP-0465064-A2 Resist and process for forming patterns using the same FUJITSU LIMITED (JP) 1992-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12578638-B2 Photopolymer composition for hologram formation, hologram recording medium and optical elements PTK2B, PTK2, CYBA TSHR 3550/4885CYP3A4 2476/4885GPR35 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.